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The brucellae are facultative intracellular bacteria that cause a worldwide extended
zoonosis. One of the pathogenicity mechanisms of these bacteria is their ability to
avoid rapid recognition by innate immunity because of a reduction of the pathogen-
associated molecular pattern (PAMP) of the lipopolysaccharide (LPS), free-lipids, and
other envelope molecules. We investigated the Brucella homologs of lptA, lpxE, and
lpxO, three genes that in some pathogens encode enzymes that mask the LPS
PAMP by upsetting the core-lipid A charge/hydrophobic balance. Brucella lptA, which
encodes a putative ethanolamine transferase, carries a frame-shift in B. abortus but
not in other Brucella spp. and phylogenetic neighbors like the opportunistic pathogen
Ochrobactrum anthropi. Consistent with the genomic evidence, a B. melitensis lptA
mutant lacked lipid A-linked ethanolamine and displayed increased sensitivity to
polymyxin B (a surrogate of innate immunity bactericidal peptides), while B. abortus
carrying B. melitensis lptA displayed increased resistance. Brucella lpxE encodes a
putative phosphatase acting on lipid A or on a free-lipid that is highly conserved in all
brucellae and O. anthropi. Although we found no evidence of lipid A dephosphorylation,
a B. abortus lpxE mutant showed increased polymyxin B sensitivity, suggesting the
existence of a hitherto unidentified free-lipid involved in bactericidal peptide resistance.
Gene lpxO putatively encoding an acyl hydroxylase carries a frame-shift in all brucellae
except B. microti and is intact in O. anthropi. Free-lipid analysis revealed that lpxO
corresponded to olsC, the gene coding for the ornithine lipid (OL) acyl hydroxylase
active in O. anthropi and B. microti, while B. abortus carrying the olsC of O. anthropi
and B. microti synthesized hydroxylated OLs. Interestingly, mutants in lptA, lpxE, or olsC
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were not attenuated in dendritic cells or mice. This lack of an obvious effect on virulence
together with the presence of the intact homolog genes in O. anthropi and B. microti but
not in other brucellae suggests that LptA, LpxE, or OL β-hydroxylase do not significantly
alter the PAMP properties of Brucella LPS and free-lipids and are therefore not positively
selected during the adaptation to intracellular life.
Keywords: lipopolysaccharide, Brucella, lipids, cell envelope, PAMP
INTRODUCTION
Brucellosis is the collective name of a group of zoonotic
diseases aﬄicting a wide range of domestic and wild mammals
(Whatmore, 2009; Zheludkov and Tsirelson, 2010). In domestic
livestock brucellosis is manifested mostly as abortions and
infertility, and contact with infected animals and consumption
of unpasteurized dairy products are the sources of human
brucellosis, an incapacitating condition that requires prolonged
antibiotic treatment (Zinsstag et al., 2011). Eradicated in a
handful of countries, brucellosis is endemic or even increasing in
many areas of the world (Jones et al., 2013; Ducrotoy et al., 2017;
Lai et al., 2017).
This disease is caused by facultative intracellular parasites
of the genus Brucella. Taxonomically placed in the α-2
Proteobacteria (Moreno et al., 1990), the brucellae are close
to plant pathogens and endosymbionts such as Agrobacterium,
Sinorhizobium, and Rhizobium and to soil bacteria such
as Ochrobactrum, the latter including some opportunistic
pathogens, and comparative analyses suggest that soil bacteria
of this group are endowed with properties that represent a first
scaffold on which an intracellular life style develops (Velasco
et al., 2000; Moreno and Moriyón, 2007; Barquero-Calvo et al.,
2009). The brucellae owe their pathogenicity mainly to their
ability to multiply within dendritic cells, macrophages, and a
variety of other cells. Due to their ability to control intracellular
trafficking and be barely detected by innate immunity, these
bacteria are able to reach a safe intracellular niche before
an effective immune response is mounted, and to multiply
extensively (Gorvel and Moreno, 2002; Barquero-Calvo et al.,
2007). A mechanism used by Brucella to scape from the
host immune response is the interference with the toll-like
receptor (TLR) signaling pathway by the injection of active
effectors such as BtpA and BtpB through the Type IV secretion
system T4SS. Both effector proteins contain a TIR domain
that interferes with TLR signaling by directly interacting with
MyD88 (Cirl et al., 2008; Salcedo et al., 2008, 2013; Chaudhary
et al., 2012) and contribute to the control of dendritic cell (DC)
activation during infection. Moreover, Brucella has modified
outer membrane (OM) components in order to reduce the
pathogen-associated molecular patterns (PAMP) of the cell
envelope. In Gram-negative bacteria, these PAMP are created by
the conserved composition of the OM lipopolysaccharide (LPS)
and the free lipids on which the topology of the OM also depends.
However, in addition to free-lipid species present in most Gram-
negative bacteria (i.e., cardiolipin, phosphatidylglycerol,
and phosphatidylethanolamine), Brucella also possesses
phosphatidylcholine and amino lipids. Phosphatidylcholine
is a eukaryotic-type phospholipid required for Brucella full
virulence (Comerci et al., 2006; Conde-Alvarez et al., 2006).
Among the amino lipids, only the ornithine lipids (OL) have
been investigated which unlike their counterparts in Bordetella,
do not trigger the release of IL-6 or TNF-α by macrophages,
possibly on account of their longer acyl chains that reduce the OL
PAMP (Palacios-Chaves et al., 2011). Concerning the LPS, most
bacteria carry C1 and C4′ glucosamine disaccharides with C12
and C14 acyl and acyl-oxyacyl chains. This highly amphipathic
structure, named lipid A, is adjacent to additional negatively
charged groups of the core oligosaccharide, namely the heptose
phosphates and 2-keto-3-deoxyoctulosonate carboxyl groups
(Kastowsky et al., 1992; Moriyón, 2003). This lipid A-core PAMP
is so efficiently detected by the innate immunity system that some
pathogens partially conceal it by removing phosphate groups or
substituting them with arabinosamine and/or ethanolamine, or
by hydroxylating the acyl chains (Takahashi et al., 2008; Lewis
et al., 2013; Moreira et al., 2013; Needham and Trent, 2013; Llobet
et al., 2015; Trombley et al., 2015). In contrast, Brucella lipid
A is a diaminoglucose disaccharide amide-linked to long (C16,
C18) and very long (C28–C30) acyl chains (Velasco et al., 2000;
Iriarte et al., 2004; Fontana et al., 2016). Furthermore, negative
charges in lipid A phosphates and 2-keto-3-deoxyoctulosonate
are counterbalanced by four glucosamine units present in the
core (Kubler-Kielb and Vinogradov, 2013; Fontana et al., 2016).
As illustrated by the unusually reduced endotoxicity of the
Brucella LPS this structure is defectively detected by the innate
immune response (Lapaque et al., 2005; Martirosyan et al., 2011;
Conde-Álvarez et al., 2012). It remains unknown, however,
whether Brucella LPS undergoes post-synthetic modifications
that have been described for other bacteria that could alter
its PAMP potential and contribution to virulence. In this
work, we investigated in Brucella the role of gene homologs to
phosphatases, phospho-ethanolamine (pEtN) transferases, and
acyl hydroxylases (Figure 1) that have been shown in other
Gram-negative pathogens to act on LPS and to contribute to
overcoming innate immunity defenses.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
The bacterial strains and plasmids used in this study are listed
in Supplementary Table S1. Bacteria were routinely grown in
standard tryptic soy broth or agar either plain or supplemented
with kanamycin at 50 µg/ml, or/and nalidixic at 5 or 25 µg/ml
or/and 5% sucrose. All strains were stored in skim milk
at−80◦C.
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FIGURE 1 | Brucella lipid A and hypothetical sites of action of putative LpxE, LptA, and LpxO. The structure proposed is based on acyl-chain and mass
spectrophotometry analyses and genomic predictions. The predicted sites of action of LpxE (phosphatase), LptA (pEtN transferase), and LpxO (acyl chain
hydroxylase) are indicated, and the corresponding ORF of B. microti (green), B. melitensis (blue), and B. abortus (red) presented (NA, not annotated). The B. abortus
lptA homolog and the B. melitensis and B. abortus lpxO homologs carry a frame-shift mutation.
DNA Manipulations
Genomic sequences were obtained from the Kyoto Encyclopedia
of Genes and Genomes (KEGG) database1. Searches for DNA
and protein homologies were carried out using the National
Center for Biotechnology Information (NCBI2) and the
European Molecular Biology Laboratory (EMBL) – European
Bioinformatics Institute server3. Primers were synthesized
by Sigma-Genosys (Haverhill, United Kingdom). DNA
sequencing was performed by the “Servicio de Secuenciación
del Centro de Investigación Médica Aplicada” (Pamplona,
Spain). Restriction–modification enzymes were used under the
conditions recommended by the manufacturer. Plasmid and
chromosomal DNA were extracted with Qiaprep Spin Miniprep
(Qiagen) and Ultraclean Microbial DNA Isolation Kits (Mo Bio
Laboratories), respectively. When needed, DNA was purified
from agarose gels using the Qiack Gel Extraction Kit (Qiagen).
1http://www.genome.jp/kegg/
2http://www.ncbi.nlm.nih.gov/
3http://www.ebi.ac.uk/
Mutagenesis
To obtain Bme1lptA, Ba1lpxE, and Bmi1olsC in-frame deletion
mutants, directed mutagenesis by overlapping PCR were
performed using genomic DNA as template and pJQK (Scupham
and Triplett, 1997) as the suicide vector. The corresponding gene
was deleted using allelic exchange by double recombination as
previously described (Conde-Alvarez et al., 2006).
For the construction of the Bme1lptA mutant, we first
generated two PCR fragments: oligonucleotides lptA-F1 (5′-GAA
CGCGAGACTATGGAAAC-3′) and lptA-R2 (5′-TGGT
GAACGCCAGAAGATAGA-3′) were used to amplify a
400-bp fragment including codons 1–26 of BmelptA ORF,
as well as 324 bp upstream of the BmelptA start codon, and
oligonucleotides lptA-F3 (5′-TCTATCTTCTGGCGTTCACC
GCACGACAATCTCTTC-3′) and lptA-R4 (5′-AATATTCCAT
GGCGCATTTC-3′) were used to amplify a 472-bp fragment
including codons 506–544 of the lptA ORF and 353-bp
downstream of the lptA stop codon. Both fragments were ligated
by overlapping PCR using oligonucleotides lptA-F1 and lptA-R4
for amplification, and the complementary regions between
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lptA-R2 and lptA-F3 for overlapping. The resulting fragment,
containing the lptA deleted allele, was cloned into pCR2.1
(Invitrogen, Barcelona, Spain), sequenced to ensure maintenance
of the reading frame, and subcloned into the BamHI and the
XbaI sites of the suicide plasmid pJQK. The resulting mutator
plasmid (pRCI-32) was introduced in B. melitensis 16M by
conjugation using the Escherchia coli S.17 strain (Simon et al.,
1983).
For the construction of the Ba1lpxE mutant, we first
generated two PCR fragments: oligonucleotides lpxE-F1 (5′-
CGCGTGTGCCATAGGTATATT-3′) and lpxE-R2 (5′-TATAGG
CAGGGCGCAGAA-3′) were used to amplify a 482-bp fragment
including codons 1–29 of lpxE ORF, as well as 394 bp upstream of
the lpxE-1 start codon, and oligonucleotides lpxE-F3 (5′-TTCTG
CGCCCTGCCTATAGATTCGTTTCCGCATGGT-3′) and lpxE-
R4 (5′-CCAATACAC CCGTCATGAGA-3′) were used to amplify
a 577-bp fragment including codons 226–255 of the lpxE ORF
and 488-bp downstream of the lpxE stop codon. Both fragments
were ligated by overlapping PCR using oligonucleotides lpxE-F1
and lpxE-R4 for amplification, and the complementary regions
between lpxE-R2 and lpxE-F3 for overlapping. The resulting
fragment, containing the lpxE deleted allele, was cloned into
pCR2.1 (Invitrogen, Barcelona, Spain), sequenced to ensure
maintenance of the reading frame, and subcloned into the BamHI
and the XbaI sites of the suicide plasmid pJQK (Scupham and
Triplett, 1997). The resulting mutator plasmid (pRCI-36) was
introduced in B. abortus 2308 by conjugation using the E. coli
S.17 strain (Simon et al., 1983).
For the construction of the Bmi1olsC mutant, we first
generated two PCR fragments: oligonucleotides olsC-F1 (5′-
TGCTGGATCGTATTCGTCTG-3′) and olsC-R2 (5′-GCCATAA
GCCGATGGAACTA-3′) were used to amplify a 334-bp fragment
including codons 1–15 of olsC ORF, as well as 289 bp upstream
of the olsC start codon, and oligonucleotides olsC-F3 (5′-TA
GTTCCATCGGCTTATGGCAGGAGGGGCTAGACAACCAC-
3′) and olsC-R4 (5′-AACCAGCGACAGGGTAAGC-3′) were
used to amplify a 320-bp fragment including codons 286–313
of the olsC ORF and 237-bp downstream of the olsC stop
codon. Both fragments were ligated by overlapping PCR using
oligonucleotides olsC-F1 and olsC-R4 for amplification, and
the complementary regions between olsC-R2 and olsC-F3 for
overlapping. The resulting fragment, containing the lptA deleted
allele, was cloned into pCR2.1 (Invitrogen, Barcelona, Spain),
sequenced to ensure maintenance of the reading frame, and
subcloned into the BamHI and the XbaI sites of the suicide
plasmid pJQK (Scupham and Triplett, 1997). The resulting
mutator plasmid (pRCI-65) was introduced in B. microti CM445
by conjugation using the E. coli S.17 strain (Simon et al., 1983).
Deletion of each gene was checked with oligonucleotides
gene-F1 and gene-R4 and internal primers hybridizing in the
non-deleted regions.
Complementation of Deleted Genes
For pBMElpxE and pBMElptA construction we took advantage
of the Brucella ORFeome constructed with the Gateway cloning
Technology (Invitrogen) (Dricot et al., 2004). The clones carrying
BmelpxE or BmelptA were extracted and the DNA containing
the corresponding ORF was subcloned in plasmid pRH001
(Hallez et al., 2007) to produce pBMElpxE and pBMElptA.
For pBMIolsC, olsC was amplified using genomic DNA of
Bmi-parental as DNA template. The primers used were olsC-
F6 (5′-GCTTTCCGAACAAGCACTGA-3′) and olsC-R7 (5′-
GCCTCCCTTCACCGGTTATT-3′). The resulting PCR product,
containing the ORF from 342 bp upstream to 84 bp downstream,
was then cloned into pCR2.1 TOPO (Invitrogen) plasmid by
“TA cloning” (Life Technologies). The resulting plasmid was
sequenced to ensure that the gene was correctly cloned. Then,
the gene was subcloned into the BamHI and the XbaI sites
of the replicative plasmid pBBR1 MCS (Kovach et al., 1994)
pBMElpxE, pBMElptA, and pBMIolsC were introduced into
Brucella by conjugation using E. coli S.17-1 strain and the
conjugants harboring corresponding plasmid were selected by
plating onto TSA-Nal-Cm plates.
Sensitivity to Cationic Peptides
Exponentially growing bacteria were adjusted to an optical
density equivalent to one of the McFarland scale and the
minimal inhibitory concentrations (MICs) of polymyxin B were
determined by the e-test method on Müller–Hinton agar (Izasa)
or by the serial dilution method in a similar broth.
LPS Preparation
Lipopolysaccharide was obtained by methanol precipitation of
the phenol phase of a phenol–water extract (Leong et al., 1970).
This fraction [10 mg/ml in 175 mM NaCl, 0.05% NaN3, 0.1 M
Tris–HCl (pH 7.0)] was then purified by digestion with nucleases
[50 µg/ml each of DNase-II type V and RNase-A (Sigma, St.
Louis, MO, United States), 30 min at 37◦C] and three times
with proteinase K (50 µg/ml, 3 h at 55◦C), and ultracentrifuged
(6 h, 100,000 × g) (Aragón et al., 1996). Free lipids (OLs and
phospholipids) were then removed by a fourfold extraction with
chloroform–methanol [2:1 (vol/vol)] (Velasco et al., 2000).
Infections in Mice
Seven-week-old female BALB/c mice (Charles River, Elbeuf,
France) were kept in cages with water and food ad libitum and
accommodated under biosafety containment conditions 2 weeks
before the start of the experiments. To prepare inocula, tryptic
soy agar (TSA) grown bacteria were harvested and suspended in
10 mM phosphate buffered saline (pH 6.85), and 0.1 ml/mouse
containing approximately 5 × 104 colony forming units (CFU)
for B. melitensis or B. abortus and 1 × 104 CFU for B. microti
was administered intraperitoneally. The exact doses assessed
retrospectively by plating dilutions of the inocula. Number of
CFU in spleens was determined at diferent time after inoculation.
For this, the spleens were aseptically removed and individually
weighed and homogenized in 9 volumes of PBS. Serial 10-fold
dilutions of each homogenate were performed and each dilution
was plated by triplicate. Plates were incubated at 37◦C for 5 days.
At several points during the infection process, the identity of
the spleen isolates was confirmed by PCR. The individual data
were normalized by logarithmic transformation, and the mean
log CFU/spleen values and the standard deviations (n = 5) were
calculated.
Frontiers in Microbiology | www.frontiersin.org 4 January 2018 | Volume 8 | Article 2657
fmicb-08-02657 January 9, 2018 Time: 16:56 # 5
Conde-Álvarez et al. Genes Remodeling Brucella Cell Envelope
Intracellular Multiplication Assays
Bone marrow cells were isolated from femurs of 7–8-
week-old C57Bl/6 female and differentiated into dendritic
cells [bone-marrow derived dendritic cells (BMDCs)] as
described by Inaba et al. (1992). Infections were performed
by centrifuging the bacteria onto the differentiated cells
(400 x g for 10 min at 4◦C; bacteria:cells ratio of 30:1
followed by incubation at 37◦C for 30 min under a 5%
CO2 atmosphere). BMDCs were gently washed with medium
to remove extracellular bacteria before incubating in medium
supplemented with 50 µg/ml gentamicin for 1 h to kill
extracellular bacteria. Thereafter, the antibiotic concentration
was decreased to 10 µg/ml. To monitor Brucella intracellular
survival at different time-points post-infection, BMDC were
lysed with 0.1% (vol/vol) Triton X-100 in H2O and serial
dilutions of lysates were plated onto TSA plates to enumerate
the CFU.
Flow Cytometry
To assess activation and maturation, BMDC were analyzed
for surface expression of classical maturation markers at 24 h
post-treatment with the different Brucella strains and derived
mutants. Cells were labeled with fluorochrome-conjugated
antibodies specific for mouse CD11c:APC-Cy7 (clone N418),
IA-IE:PE (MHC class II clone M5/114.15.2) (PE), CD86:FITC
(Clone GL-1), CD40:APC (clone 3/23), and CD80:PE-Cy5 (clone
16-10A1), all from BioLegend. Labeled cells were then subjected
to multi-color cytometry using a LSR II UV (Becton Dickinson)
and the data analyzed using FlowJo Software by first gating on
the CD11c+ population (100,000 events) prior to quantifying
expression of receptors. Cells were stimulated with E. coli LPS
(055:B5) as a positive control.
Lipid A Extraction
Five milligrams of LPS was hydrolyzed in 5 ml 1% acetic acid by
sonication, heating to 100◦C for 30 min, and cooling to room
temperature. Concentrated HCl was added to the mixture until
the pH was 1–2. The solution was converted to a two-phase
acidic Bligh–Dyer mixture by adding 5.6 ml of chloroform and
5.6 ml of methanol. Phases were mixed by inverting the tubes
and separated by centrifugation at 4000 × g for 20 min. The
lower phases containing lipid A were collected, washed two times
with water, and dried under a stream of nitrogen. Extraction was
repeated, and the lower phases (11.2 ml) were combined and
neutralized with a drop of pyridine. Samples were evaporated to
dryness under a stream of nitrogen.
Mass Spectrometry
Mass spectrometra were acquired on a Bruker Autoflex R©Speed
TOF/TOF Mass Spectrometer (Bruker Daltonics Inc.) in negative
reflective mode with delayed extraction. The ion-accelerating
voltage was set at 20 kV. Each spectrum was an average of 300
shots. A peptide calibration standard (Bruker Daltonics Inc.) was
used to calibrate the Matrix Assisted Laser Desorption/Ionization
Time-of-Flight (MALDI-TOF), and lipid A extracted from E. coli
strain MG1655 grown in LB medium at 37◦C.
Extraction and Analysis of Envelope
Lipids
The free-lipid fraction was extracted as described by Bligh
and Dyer (1959), and analyzed on a silica gel 60 high-
performance thin layer chromatography (HPLC) plates (Merck,
Darmstadt, Germany). Chromatography was performed either
monodimensionally with chloroform–methanol–water [14:6:1
(volume)] or bidimensionally with chloroform–methanol–water
[14:6:1 (volume)] first and chloroform–methanol–acetic acid
[13:5:2 (volume)] in the second dimension (Weissenmayer et al.,
2002). Plates were developed with 0.2% ninhydrin in acetone at
180◦C or 15% sulfuric acid in ethanol at 180◦C.
RESULTS
The Brucella lptA Orthologs Encode a
Lipid A Phosphate-Ethanolamine
Transferase
A genomic search in the KEGG database revealed that all Brucella
spp. carry an ORF (BMEI0118 in B. melitensis) homologous
to Neisseria meningitidis lptA, a pEtN transferase that modifies
lipid A (Cox et al., 2003). Strikingly, in B. abortus but not
in other Brucella spp., all genomic sequences available at
KEGG show a deletion of a thymine in position 774 that
should result in a truncated protein lacking the amino acids
related to the enzymatic activity (Naessan et al., 2008; Figure 1
and Supplementary Figure S1 and Supplementary Table S2).
In addition to LptA, two other pEtN transferases have been
identified in N. meningitidis: Lpt-3 and Lpt-6, which, respectively,
modify the LPS core at the third and sixth position of heptose II
(Mackinnon et al., 2002; Wright et al., 2004). By multiple
sequence alignment, the B. melitensis putative pEtN transferase
showed highest homology with Neisseria LptA and also displayed
the LptA membrane-associated domains not present in Lpt-3 and
Lpt-6 (ORFs NMB1638, NMB2010, and NMA0408, respectively).
Accordingly, it can be predicted that ORF BMEI0118 (henceforth
BMElptA) encodes a pEtN transferase that acts on lipid A, a
hypothesis fully consistent with the absence of heptose in the
Brucella LPS core (Iriarte et al., 2004; Fontana et al., 2016).
To test this hypothesis, we constructed a B. melitensis
non-polar mutant (Bme1lptA) lacking the LptA enzymatic
domain (amino acids 26–506), which as expected maintained a
smooth (S) phenotype (negative crystal violet test and positive
coagglutination with anti-S-LPS antibodies). As a consequence
of the increased positive charge of the amino group, pEtN has
been shown to decrease binding of the polycationic lipopeptide
polymyxin B to LPS, and to increase resistance to this antibiotic
in a variety of bacteria (Needham and Trent, 2013; Trombley
et al., 2015; Herrera et al., 2017). In keeping with this possibility,
the Bme1lptA mutant was more sensitive to polymyxin B
than the parental strain B. melitensis 16M (Bme-parental)
(Figure 2A). In contrast, and consistent with the frame-shift
in its lptA homolog, B. abortus 2308 (Ba-parental) displayed
polymyxin B sensitivity similar to that of Bme1lptA. Moreover,
complementation of Bme1lptA with the multi-copy plasmid
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FIGURE 2 | The Brucella lptA orthologs are involved in polymyxin B resistance
and code for a phosphate-ethanolamine transferase acting on lipid A.
(A) Polymyxin B sensitivity of B. melitensis wild-type (Bme-parental),
B. melitensis non-polar lptA mutant (BmelptA), the cognate complemented
mutant (Bme1lptApBMElptA), B. abortus wild-type (Ba-parental), and
B. abortus wild-type carrying a plasmid with the B. melitensis lptA gene
(Ba-parentalpBMElptA) (the results are representative of three independent
experiments). (B) MALDI-TOF analysis of the lipid A of Bme-parental,
Bme1lptA, and Ba-parental.
pBMElptA or its introduction into B. abortus 2308 leads to
restoration of polymyxin B resistance in Bme1lptA or an increase
up to B. melitensis level in B. abortus (Figure 2A). As expected
both constructs kept the S type features (negative crystal violet
test and positive coagglutination with anti-S-LPS antibodies) of
the parental strains. N. gonorrhoeae shows increased resistance
to the action of complement in non-immune serum that is
dependent on lipid A-linked pEtN (Lewis et al., 2013). Testing for
a similar contribution here, we found that Bme1lptA was more
sensitive than either the parental strain or the complemented
mutant (25% vs. no decrease in viability after 3 h of incubation
in normal sheep serum) relevant given that B. melitensis is
characteristically resistant to killing by normal serum.
By MALDI-TOF analysis, the lipid A of Bme-parental was
found to contain four main clusters of ions (A, B, C, and D
in Figure 2B). Bme1lptA lipid A was qualitatively identical to
Bme-parental with respect to groups A, B, and C but clearly
differed in group D (Figure 2B and Supplementary Table S3).
In group D, the 2191 m/z′′ species of Ba-parental was consistent
with the isotopic mass of a molecule (C120H232N4O25P2)
formed by a hexaacylated and bisphosphorylated diaminoglucose
disaccharide carrying the hydroxylated long and very long chain
acyl groups characteristic of Brucella (Velasco et al., 2000;
Ferguson et al., 2004). According to this interpretation, the
signal(s) at 2112 m/z (mass of - H2PO3 o - HPO3 -, 80.9 - 79.9)
could correspond to a monophosphorylated (C120H232N4O25P)
2191 m/z′′ equivalent. Substitution of this monophosphorylated
form with pEtN (+H3NCH2-CH2- HPO3 mass 125) should
account for signal m/z 2237, in keeping with the fact that m/z
2237 did not appear in the spectrum of the lipids A from either
Bme1lptA or Ba-parental (Figure 2B). Although a clear cut
demonstration requires direct analyses of the enzymatic analyses
of LptA, these results and the homologies with LptA of other
bacteria are consistent with the hypothesis that LptA acts as
a pEtN transferase in B. melitensis and lacks functionality in
B. abortus. It is remarkable that pEtN activity was detected for
only a fraction (D) of lipid A species. This could be explained
by a preferential activity of the enzyme for higher MW lipid A
molecules.
The Brucella lpxE Orthologs Encode a
Phosphatase Involved in the Remodeling
of the OM
As described above, MALDI-TOF analyses showed the
presence of molecular species with a mass compatible
with monophosphorylated lipid A. Since lipid A synthesis
produces C1 and C4′ bisphosphorylated disaccharide backbones
(Qureshi et al., 1994), a possible explanation could be its
dephosphorylation by a phosphatase such as LpxE, an inner
membrane enzyme that in the phylogenetic neighbor Rhizobium
leguminosarum removes the lipid A phosphate at C1 (Raetz
et al., 2009). A search in KEGG showed that all Brucella
spp. carry an ORF homologous to R. leguminosarum lpxE
(Supplementary Table S2). However, the start codon in the
B. melitensis 16M homolog (BMEI1212) is annotated to a
position different from that determined for other brucellae
(Supplementary Table S2), including other B. melitensis strains.
Thus, whereas the B. abortus homolog (BAB1_0671) is predicted
to encode a protein of 255 amino acids, the B. melitensis
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one could encode a protein of either 235 or 255 amino acids
(Figure 1). Both proteins conserve the consensus sequence of
the lipid phosphatase superfamily [KX6RP-(X12–54)-PSGH-
(X31–54)-SRX5HX3D] (Stukey and Carman, 2008) which is also
present in LpxE from R. leguminosarum, Sinorhizobium meliloti,
and Agrobacterium tumefaciens (Karbarz et al., 2003). Although
BAB1_0671 and BMEI1212 code for proteins that contain the
three motifs conserved in the LpxF phosphatase from Francisella,
they lack two amino acids of the central motif, NCSFX2G, which
seems LpxF specific (Wang et al., 2006, 2007). Thus, the Brucella
proteins were named BALpxE and BMELpxE.
To study whether BALpxE actually acts as a lipid A
phosphatase, we constructed a non-polar mutant (Ba1lpxE)
and tested it against polymyxin B, since the permanence of a
phosphate group in an OM molecule should increase sensitivity
to this antibiotic. Mutant Ba1lpxE was eight times more sensitive
than the parental strain (MIC 0.2 and 1.6 µg/ml, respectively).
Moreover, when we introduced a plasmid containing the
BMElpxE ortholog into Ba1lpxE, the resistance to polymyxin B
was restored (MIC 1.6 µg/ml). Although final confirmation of
this interpretation would require to assay the enzymatic activity
of the protein, these results are consistent with the predicted role
of lpxE as a phosphatase and its functionality in both B. abortus
and B. melitensis 16M, a strain where the annotation of the start
codon was a source of ambiguity.
By MALDI-TOF analysis, the Ba-parental lipid A spectrum
showed three of the four predominant clusters of ions (A, B,
and C) found in B. melitensis (Figure 2B and Supplementary
Table S3). Cluster A (m/z 2173) was consistent with an
hexaacylated bisphoshorylated diaminoglucose disaccharide
(C120H232N4O24P2) and the signal at 2093 m/z, which differed
in the mass of one phosphate group (i.e., 80), was consistent with
the cognate monophosphorylated lipid A (C120H232N4O25P)
(A-Pi, Figure 2). Other signals differing in a mass of 14 or 28
units should result from the heterogeneity in acyl chain length
that is typical of lipid A. The B and C clusters also contained
signals differing in 80 mass units that could correspond to
bis- and mono-phosphorylated species. The mass spectrum of
Ba1lpxE lipid A (not shown) did not differ significantly from
that of Ba-parental, and again showed acyl chain heterogeneity
in the A, B, C clusters, as well as the −80 m/z signals indicative
of mono- and bisphoshorylated lipid A species. As mutation of
lpxE is concomitant with an increase in polymyxin B sensitivity,
it is tempting to speculate that LpxE directly or indirectly
modulates Brucella cell envelope by removing an accessible
phosphate group from a substrate different from lipid A.
Further studies need to be performed to clarify the role of
LpxE.
The Brucella lpxO Orthologs Encode an
Acyl Hydroxylase Acting on Ornithine
Lipids
The genomes of all Brucella species available at KEGG contain
an ORF homologous to Salmonella lpxO (Gibbons et al., 2000),
which encodes an enzyme hydroxylating the 3′-secondary acyl
chain of lipid A. In all Brucella spp. except B. microti and B. vulpis
this ORF presents a frame-shift leading to a truncated protein that
lacks the consensus of the aspartyl/asparaginyl β-hydroxylases
family to which LpxO belongs (Figure 1 and Supplementary
Table S2). These characteristics are consistent with chemical
studies that previously failed to observe S2 hydroxylated fatty
acids in B. abortus lipid A (Velasco et al., 2000). Moreover, a
lpxO homolog is present in Ochrobactrum anthropi where S2
hydroxylated fatty acids were also not observed in the lipid A
(Velasco et al., 2000), indicating that a role similar to that of
Salmonella LpxO is unlikely. Thus, the lpxO homologs present
in these B. microti and O. anthropi could be acting on a free
lipid and, in fact, it has been reported that the corresponding
R. tropici homolog is a β-hydroxylase acting on OLs (Vences-
Guzmán et al., 2011). If this were the case in O. anthropi
and the brucellae, the end product [a hydroxylated OL (OH–
OL)] of the pathway described previously in members of the
Rhizobiaceae (Figure 3A) should be observed in O. anthropi
and B. microti (and B. vulpis) but not in other Brucella
spp.
To investigate these hypotheses, we compared the free lipids
of B. abortus, B. melitensis, B. suis, B. ovis, B. microti, and
O. anthropi. As can be seen in Figure 3B, B. microti but
not B. abortus produced an amino lipid with the migration
pattern predicted for OH-OL (Vences-Guzmán et al., 2011),
and results similar to those of B. microti were obtained for
O. anthropi but not for the other Brucella spp. tested (not
shown). These observations support the interpretation that
O. anthropi and B. microti LpxO are OL hydroxylases and are
fully consistent with the aforementioned genomic and chemical
evidence. Accordingly, Brucella lpxO should be named olsC. To
confirm this, we examined the amino lipids of a non-polar olsC
mutant in B. microti (Bmi1olsC). As predicted, this mutant did
not synthesize OH–OL and complementation with a plasmid
containing B. microti olsC restored the wild-type phenotype
(Figure 3C). Furthermore, introducing this plasmid or a plasmid
carrying O. anthropi olsC into B. abortus resulted in the
synthesis of OH–OL (Figure 3C and Supplementary Figure S2).
No difference in polymyxin sensitivity was observed in these
constructs or the mutant Bmi1olsC when compared to the
corresponding parental strains.
LptA, LpxE, and OlsC Are Not Required
for Brucella Virulence in Laboratory
Models
Brucella abortus, B. melitensis, and B. suis have been shown
to multiply in murine and human monocyte-derived dendritic
cells while interfering with their activation and maturation and
reducing both antigen presentation and an effective adaptive
response (Billard et al., 2007; Martirosyan et al., 2011; Conde-
Álvarez et al., 2012; Gorvel et al., 2014; Papadopoulos et al.,
2016). To assess whether LptA, LpxE, and OL β-hydroxylase
(OlsC) were involved, we compared parental and mutant strains
of B. melitensis, B. abortus, and B. microti in mouse BMDCs.
As shown in Figure 4, the kinetics of multiplication of the
mutants and wild-type strains were similar. We also performed
a phenotypic characterization of MHC II and co-stimulatory
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FIGURE 3 | The Brucella lpxO orthologs encode an acyl hydroxylase acting
on ornithine lipids. (A) Pathway of synthesis of ornithine lipids in α-2
Proteobacteria (adapted from Geiger et al., 2010); the ORFs of B. abortus and
B. microti are indicated, whereas B. microti, B. vulpis, and O. anthropi contain
an intact olsC acyl hydroxylase gene, B. abortus and other Brucella spp. carry
a frame-shift in the olsC homolog. (B) Lipid profile of B. abortus wild-type
(Ba-parental) and B. microti wild-type (Bmi-parental) showing the absence or
presence, respectively, of OH–OL. (C) Amino lipid profile of B. abortus
wild-type (Ba-parental), B. microti wild-type (Bmi-parental), B. microti deleted
in olsC (Bmi1olsC), the cognate reconstituted mutant (Bmi1olsCpOlsC), and
B. abortus wild-type carrying a plasmid with the B. microti olsC gene
(Ba-parentalpOlsC).
receptors CD86 and CD80 (Figure 5). In agreement with
previous studies, these analyses showed that activation and
maturation was only partially induced in BMDC infected with
B. melitensis and B. abortus (Martirosyan et al., 2011). In
addition, a similar partial-activation profile was evident both for
B. microti, for which no previous studies exist in infected BMDC,
and all of the tested mutants obtained for each of the three
Brucella spp.
The mouse model has been widely used for testing Brucella
virulence (Grilló et al., 2012). In this model, the LptA and
LpxE mutants and the parental strains behaved identically
(Figure 6 upper panels). Deletion of olsC in B. microti did not
FIGURE 4 | LptA, LpxE, and OlsC deletions do not alter the Brucella
interaction with dendritic cells. Intracellular replication in BMDCs (each point
represents the mean ± standard error of the logarithm of CFU in dendritic
cells).
alter the CFU/spleen profile produced by this species which is
characterized by a lower lethal dose in mice as well as a faster
clearance from mouse spleens (Jiménez de Bagüés et al., 2010;
Figure 6, lower left panel). Moreover, when we tested whether
the expression of B. microti olsC in B. abortus could affect
virulence, we found no differences between the B. microti olsC-
carrying and the wild-type B. abortus strains (Figure 6, lower
right panel).
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FIGURE 5 | LptA, LpxE, and OlsC deletions do not significantly impact the intrinsic immunogenicity of Brucella. Each point represents the mean ± standard error of
the median intensity of surface receptor expression in dendritic cells treated with Brucella strains or derived mutants. E. coli LPS was used as a positive control for
dendritic cell activation.
DISCUSSION
In this work we investigated three Brucella ORFs that according
to homologies with genes of known function in other pathogens
could modify the lipid A and contribute to further altering the
LPS PAMP of representative Brucella species. The results show
that, whereas Brucella LptA modifies the lipid A, this is not the
case for lpxE and lpxO (redesignated olsC), the former encoding a
putative phosphatase acting on an unidentified OM molecule and
the latter for an enzyme with OlsC activity.
Our data strongly suggest that B. melitensis LptA is involved
in the addition of pEtN to lipid A, homologous proteins
carrying out this function are not uncommon in Gram-negative
pathogens and modulate the properties of lipid A. In Salmonella
Typhimurium, Shigella flexneri, E. coli, Vibrio cholerae,
Helicobacter pylori, Haemophilus ducreyi, N. gonorrhoeae,
and N. meningitidis pEtN reduces the binding of cationic
bactericidal peptides by balancing the negative charge of lipid A
(Needham and Trent, 2013; Trombley et al., 2015). Conversely,
pEtN promotes binding to N. gonorrhoeae lipid A of factors that
downregulate the complement cascade and thwart building of
the membrane-attack complex and opsonophagocytosis (Lewis
et al., 2013). N. meningitidis pEtN also promotes adhesion of
non-encapsulated bacteria to endothelial cells (Takahashi et al.,
2008). Indeed, properties that parallel some of those observed
for the above-listed pathogens can also be attributed to the pEtN
transferase counterpart in Brucella. An intact lptA was related to
polymyxin B resistance in B. melitensis and the introduction of
B. melitensis lptA into B. abortus increases polymyxin B resistance
to the level of B. melitensis, suggesting that LptA function is
severally impaired in B. abortus. This is in agreement with
the presence of a frame-shift in B. abortus lptA encompassing
the consensus sequence, which makes likely that it codes for a
protein with no or residual enzymatic activity. Previous analyses
are contradictory with regard to the presence (Casabuono et al.,
2017) or absence (Moreno et al., 1990) of ethanolamine in
B. abortus lipid A but the materials analyzed differ in methods
of extraction and presence of B. abortus lipid A markers, such as
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FIGURE 6 | The OM properties that depend on LptA, LpxE, and OlsC are not required for Brucella virulence in the mouse model. BALB/c mice were inoculated
intraperitoneally with 5 × 104 (Bme-parental, Bme1lptA, Ba-parental, and Ba1lpxE) or 1 × 104 (Bmi-parental and Bmi1olsC) CFU/mouse and CFU/spleen
determined at the indicated times. Each point represents the mean ± standard error of the logarithm of CFU in the spleens of five animals.
very long chain fatty acids (VCLFA). Although further chemical
and enzymatic analyses are necessary for a definite conclusion,
our results strongly suggest that, if present, pEtN is in much
less amounts in B. abortus than in B. melitensis lipid A. It is
also worth noting that such genetic and phenotypic differences
in the lipid A of B. abortus and B. melitensis could relate to
differences in biological properties. The LPS of B. abortus and
B. melitensis is a poor activator of the complement cascade, and
this property has been traced to the core and lipid A structure
(Moreno et al., 1981; Conde-Álvarez et al., 2012; Fontana et al.,
2016). Since B. abortus is less resistant than B. melitensis to
normal serum (González et al., 2008), it is tempting to suggest
that, like in N. gonorrhoeae, B. melitensis pEtN could sequester
regulatory elements enhancing complement resistance in this
species.
Concerning LpxE, phosphatases acting on lipid A have at least
been shown in Francisella tularensis, H. pylori, Porphyromonas
gingivalis, and Capnocytophaga canimorsus, bacteria where lipid
A dephosphorylation is involved both in resistance to bactericidal
peptides and the reduction of TLR-4-dependent recognition
(Needham and Trent, 2013). Although these properties are
displayed by the LPS of B. abortus and B. melitensis (Martínez
de Tejada et al., 1995; Lapaque et al., 2006; Conde-Álvarez
et al., 2012), our results do not support a role for BALpxE as
a lipid A phosphatase. This is consistent with genomic analysis
showing that, whereas in bacteria where LpxE acts on lipid
A the gene is located together with lptA in an operon (Tran
et al., 2006; Renzi et al., 2015), Brucella lpxE is instead located
upstream of three sequences annotated as pseudogenes and
downstream, but in the opposite direction, of a cystathionine
beta-lyase. On the basis of the data shown here, the origin of
monophosphoryl lipid A in Brucella remains to be explained.
Further, we believe it unlikely to be an artifact resulting from
the hydrolytic steps used to obtain lipid A and instead favor
the hypothesis of the existence of an as yet unidentified lipid A
phosphatase.
LpxE belongs to the type 2 family of phosphatases that can
act on lipid A but also on phosphatidylglycerol phosphate,
phosphatidic acid, sphingosine phosphate, and lysophosphatidic
acid (Brindley and Waggoner, 1998; Sciorra and Morris,
2002). Significantly, LpxE from Agrobacterium, although
predicted to be a lipid A phosphatase, dephosphorylates
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phosphatidyl glycerophosphate (Karbarz et al., 2009) to generate
phosphatidylglycerol, a cell envelope phospholipid. Indeed,
a hypothetical phosphatidyl glycerophosphate phosphatase
activity of Brucella LpxE could account for both the polymyxin
B sensitivity of the mutated bacteria and the unaltered mass
spectra of the lipid A of the mutant. Such a modification
of a phospholipid could be meaningful by itself on account
of the LpxE-dependent bactericidal peptide resistance but
there are other possibilities. In some bacteria (i.e., Rhizobium)
phosphatidylglycerol is a precursor for the synthesis of amino
lipids such as lysyl-phosphatidylglycerol. This synthesis is
induced by acid pH and brings about resistance to daptomycin
and polymyxin B (Sohlenkamp et al., 2007; Ernst and Peschel,
2011; Arendt et al., 2012). Interestingly, whereas the Ba1lpxE
mutant is impaired for growth at pH 6, the parental B. abortus
becomes more resistant to cationic peptides (L. Palacios-Chaves
and R. Conde-Álvarez, Unpublished observations). These
observations suggest the existence in Brucella of pH-dependent
envelope modifications that require a functional LpxE. Research
is in progress to elucidate the mechanisms behind the increased
resistance at acid pH and the implication regarding a role for
LpxE.
In S. Typhimurium, Pseudomonas aeruginosa, Bordetella
bronchispetica, Legionella pneumophila, and Klebsiella
pneumonia, LpxO is a Fe2+/α-ketoglutarate-dependent
dioxygenase that catalyzes the hydroxylation of the 3′-secondary
acyl chain of lipid A. LpxO has been implicated indirectly in
stress responses at the envelope level (Needham and Trent,
2013) and, in K. pneumoniae, it has been shown to be relevant
in vivo by increasing bactericidal peptide resistance and reducing
the inflammatory responses (Llobet et al., 2015). However, as
discussed above, previous chemical analysis (Velasco et al.,
2000) of lipid A and the evidence presented here indicate that
the Brucella lpxO homolog is not a lipid A hydroxylase but
rather an OlsC whose mutation, in contrast with LpxO, does
not result in increased sensitivity to polymyxin B. This absence
of an effect on polycation resistance is in keeping with both
the lack of activity on lipid A and the fact that OL do no play
a major role in resistance to polycationic bactericidal peptides
in B. abortus (Palacios-Chaves et al., 2011). At the same time, it
would also appear to rule out, the involvement of this protein in
the metabolism of succinate in B. microti as has been previously
suggested (Audic et al., 2009).
Previous data showing lptA, lpxE, and lpxO to be involved
in modulating the properties of the OM in a way that in some
cases confers in vitro resistance to innate immunity bactericidal
peptides, complement, and cytokine responses (Needham and
Trent, 2013) have been drawn upon as evidence for a role
in virulence. However, to the best of our knowledge, a
role in vivo has thus far been shown only for lpxO from
K. pneumoniae (Llobet et al., 2015). Moreover, contrasting results
have been obtained with mutants both showing bactericidal
peptide sensitivity in vitro and no phenotype in vivo have been
reported for at least H. ducreyi (Trombley et al., 2015) and may
reflect the complexities of the infection processes and/or the
inadequacies of the currently available in vivo models. Despite
their effect on the envelope, our results show that Brucella lptA,
lpxE, or olsC do not play a role in the ability of Brucella to replicate
in BMDC and do not modulate the activation and maturation
profile in these cells. Similarly, the mouse model did not reveal
any effect on its ability to colonize and multiply in the spleen.
However, further experimental work in the natural hosts and
alternative routes of infection might provide evidence on the
role in virulence of these genes. The fact that lptA and olsC are
not functional in all Brucella spp. must therefore be considered
in the context of the models used. While the absence of a
functional lptA in B. abortus suggests that the gene is not essential
for the virulence of this species we cannot conclude it to be
totally irrelevant. Differences between B. melitensis and B. abortus
related to lptA could explain the higher invasiveness of the former
species noted by early researchers in studies carried out in guinea
pigs, animals that are highly susceptible to brucellosis (Braude,
1951). This possibility together with the presence of intact lptA
and olsC in Ochrobactrum and B. microti is also compatible with
the hypothesis that they represent ancestral characters that are
liable to be lost in the absence of a selective pressure during
the intracellular life cycle or, in the case of lptA, that is no
longer present in the ruminant host species (i.e., cattle) to which
B. abortus is characteristically associated.
ETHICS STATEMENT
Female BALB/c mice (Charles River, France) were kept in
cages with water and food ad libitum under P3 biosafety
conditions in the facilities of “Centro de Investigación Médica
Aplicada” (registration code ES31 2010000132) 2 weeks before
and during the experiments. The procedures were in accordance
with the current European (directive 86/609/EEC) and Spanish
(RD 53/2013) legislations, supervised by the Animal Welfare
Committee of the University of Navarra, and authorized by the
“Gobierno de Navarra” [CEEA045/12 and E36-14 (045-12E1)].
AUTHOR CONTRIBUTIONS
IM, MI, J-PG, JB, and RC-Á conceived the study. RC-Á, LP-C,
YG-R, MB-V, MS-B, BA-A, EM-G, AZ-R, MdM, TLB, SH, M-JG,
MV-G, and VA-G carried out the experimental work. IM, MI,
and RC-Á wrote the paper. All authors participated in the
presentation and discussion of results.
FUNDING
This research was supported by the Institute for Tropical Health
funders (Obra Social la CAIXA, Fundaciones Caja Navarra
and Roviralta, PROFAND, Ubesol, ACUNSA, and Artai) and
grants MINECO (AGL2014-58795-C4-1-R, Bru-Epidia 291815-
FP7/ERANET/ANIHWA), Aragón Government (Consolidated
Group A14), and Marie Curie Career Integration Grant U-KARE
(PCIG13-GA-2013-618162). TLB is the recipient of a Ph.D.
Fellowship funded by the Department for Employment and
Learning (Northern Ireland, United Kingdom).
Frontiers in Microbiology | www.frontiersin.org 11 January 2018 | Volume 8 | Article 2657
fmicb-08-02657 January 9, 2018 Time: 16:56 # 12
Conde-Álvarez et al. Genes Remodeling Brucella Cell Envelope
ACKNOWLEDGMENT
The authors thank A. Delgado-López for excellent
technical assistance in the extraction and purification
of LPS.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: https://www.frontiersin.org/articles/10.3389/fmicb.
2017.02657/full#supplementary-material
REFERENCES
Aragón, V., Díaz, R., Moreno, E., and Moriyón, I. (1996). Characterization of
Brucella abortus and Brucella melitensis native haptens as outer membrane
O-type polysaccharides independent from the smooth lipopolysaccharide.
J. Bacteriol. 178, 1070–1079. doi: 10.1128/jb.178.4.1070-1079.1996
Arendt, W., Hebecker, S., Jäger, S., Nimtz, M., and Moser, J. (2012).
Resistance phenotypes mediated by aminoacyl-phosphatidylglycerol synthases.
J. Bacteriol. 194, 1401–1416. doi: 10.1128/JB.06576-11
Audic, S., Lescot, M., Claverie, J.-M., and Scholz, H. C. (2009). Brucella microti:
the genome sequence of an emerging pathogen. BMC Genomics 10:352.
doi: 10.1186/1471-2164-10-352
Barquero-Calvo, E., Chaves-Olarte, E., Weiss, D. S., Guzmán-Verri, C., Chacón-
Díaz, C., Rucavado, A., et al. (2007). Brucella abortus uses a stealthy strategy
to avoid activation of the innate immune system during the onset of infection.
PLOS ONE 2:e631. doi: 10.1371/journal.pone.0000631
Barquero-Calvo, E., Conde-Alvarez, R., Chacón-Díaz, C., Quesada-Lobo, L.,
Martirosyan, A., Guzmán-Verri, C., et al. (2009). The differential interaction
of Brucella and Ochrobactrum with innate immunity reveals traits related to the
evolution of stealthy pathogens. PLOS ONE 4:e5893. doi: 10.1371/journal.pone.
0005893
Billard, E., Dornand, J., and Gross, A. (2007). Brucella suis prevents human
dendritic cell maturation and antigen presentation through regulation of tumor
necrosis factor alpha secretion. Infect. Immun. 75, 4980–4989. doi: 10.1128/IAI.
00637-07
Bligh, E. M., and Dyer, W. J. (1959). A rapid method of total lipid extraction and
purification. Can. J. Biochem. Physiol. 37, 911–917. doi: 10.1139/y59-099
Braude, A. I. (1951). Studies in the pathology and pathogenesis of experimental
brucellosis: I. A comparison of the pathogenicity of Brucella abortus, Brucella
melitensis, and Brucella suis for Guinea pigs. J. Infect. Dis. 89, 76–86.
doi: 10.1093/infdis/89.1.76
Brindley, D. N., and Waggoner, D. W. (1998). Mammalian lipid phosphate
phosphohydrolases. J. Biol. Chem. 273, 24281–24284. doi: 10.1074/JBC.273.38.
24281
Casabuono, A. C., Czibener, C., Del Giudice, M. G., Valguarnera, E., Ugalde, J. E.,
and Couto, A. S. (2017). New features in the lipid A structure of Brucella
suis and Brucella abortus lipopolysaccharide. J. Am. Soc. Mass Spectrom. 28,
2716–2723. doi: 10.1007/s13361-017-1805-x
Chaudhary, A., Ganguly, K., Cabantous, S., Waldo, G. S., Micheva-Viteva, S. N.,
Nag, K., et al. (2012). The Brucella TIR-like protein TcpB interacts with the
death domain of MyD88. Biochem. Biophys. Res. Commun. 417, 299–304.
doi: 10.1016/j.bbrc.2011.11.104
Cirl, C., Wieser, A., Yadav, M., Duerr, S., Schubert, S., Fischer, H., et al. (2008).
Subversion of Toll-like receptor signaling by a unique family of bacterial
Toll/interleukin-1 receptor domain–containing proteins. Nat. Med. 14,
399–406. doi: 10.1038/nm1734
Comerci, D. J., Altabe, S., de Mendoza, D., and Ugalde, R. A. (2006).
Brucella abortus synthesizes phosphatidylcholine from choline provided
by the host. J. Bacteriol. 188, 1929–1934. doi: 10.1128/JB.188.5.1929-1934.
2006
Conde-Álvarez, R., Arce-Gorvel, V., Iriarte, M., Manc˘ek-Keber, M., Barquero-
Calvo, E., Palacios-Chaves, L., et al. (2012). The lipopolysaccharide core of
Brucella abortus acts as a shield against innate immunity recognition. PLOS
Pathog. 8:e1002675. doi: 10.1371/journal.ppat.1002675
Conde-Alvarez, R., Grilló, M. J., Salcedo, S. P., de Miguel, M. J., Fugier, E.,
Gorvel, J. P., et al. (2006). Synthesis of phosphatidylcholine, a typical eukaryotic
phospholipid, is necessary for full virulence of the intracellular bacterial parasite
Brucella abortus. Cell. Microbiol. 8, 1322–1335. doi: 10.1111/j.1462-5822.2006.
00712.x
Cox, A. D., Wright, J. C., Li, J., Hood, D. W., Moxon, E. R., and Richards,
J. C. (2003). Phosphorylation of the lipid A region of meningococcal
lipopolysaccharide: identification of a family of transferases that add
phosphoethanolamine to lipopolysaccharide. J. Bacteriol. 185, 3270–3277.
doi: 10.1128/jb.185.11.3270-3277.2003
Dricot, A., Rual, J. F., Lamesch, P., Bertin, N., Dupuy, D., Hao, T., et al. (2004).
Generation of the Brucella melitensis ORFeome version 1.1. Genome Res. 14,
2201–2206. doi: 10.1101/gr.2456204
Ducrotoy, M., Bertu, W. J., Matope, G., Cadmus, S., Conde-Álvarez, R., Gusi,
A. M., et al. (2017). Brucellosis in sub-saharan Africa: current challenges for
management, diagnosis and control. Acta Trop. 165, 179–193. doi: 10.1016/j.
actatropica.2015.10.023
Ernst, C. M., and Peschel, A. (2011). Broad-spectrum antimicrobial peptide
resistance by MprF-mediated aminoacylation and flipping of phospholipids.
Mol. Microbiol. 80, 290–299. doi: 10.1111/j.1365-2958.2011.07576.x
Ferguson, G. P., Datta, A., Baumgartner, J., Roop, R. M., Carlson, R. W., Walker,
G. C., et al. (2004). Similarity to peroxisomal-membrane protein family reveals
that Sinorhizobium and Brucella BacA affect lipid-A fatty acids. Proc. Natl. Acad.
Sci. U.S.A. 101, 5012–5017. doi: 10.1073/pnas.0307137101
Fontana, C., Conde-Álvarez, R., Ståhle, J., Holst, O., Iriarte, M., Zhao, Y.,
et al. (2016). Structural studies of lipopolysaccharide-defective mutants from
Brucella melitensis identify a core oligosaccharide critical in virulence. J. Biol.
Chem. 291, 7727–7741. doi: 10.1074/jbc.M115.701540
Geiger, O., González-Silva, N., López-Lara, I. M., and Sohlenkamp, C. (2010).
Amino acid-containing membrane lipids in bacteria. Prog. Lipid Res. 49, 46–60.
doi: 10.1016/j.plipres.2009.08.002
Gibbons, H. S., Lin, S., Cotter, R. J., and Raetz, C. R. H. (2000). Oxygen
requirement for the biosynthesis of the S -2-hydroxymyristate moiety in
Salmonella typhimurium lipid A. J. Biol. Chem. 275, 32940–32949. doi: 10.1074/
jbc.M005779200
González, D., Grilló, M.-J., De Miguel, M.-J., Ali, T., Arce-Gorvel, V., Delrue,
R.-M., et al. (2008). Brucellosis vaccines: assessment of Brucella melitensis
lipopolysaccharide rough mutants defective in core and O-polysaccharide
synthesis and export. PLOS ONE 3:e2760. doi: 10.1371/journal.pone.000
2760
Gorvel, J.-P., and Moreno, E. (2002). Brucella intracellular life: from invasion
to intracellular replication. Vet. Microbiol. 90, 281–297. doi: 10.1016/S0378-
1135(02)00214-6
Gorvel, L., Textoris, J., Banchereau, R., Ben Amara, A., Tantibhedhyangkul, W.,
von Bargen, K., et al. (2014). Intracellular bacteria interfere with dendritic
cell functions: role of the type I interferon pathway. PLOS ONE 9:e99420.
doi: 10.1371/journal.pone.0099420
Grilló, M.-J., Blasco, J. M., Gorvel, J. P., Moriyón, I., and Moreno, E. (2012).
What have we learned from brucellosis in the mouse model? Vet. Res. 43:29.
doi: 10.1186/1297-9716-43-29
Hallez, R., Letesson, J.-J., Vandenhaute, J., and De Bolle, X. (2007). Gateway-based
destination vectors for functional analyses of bacterial ORFeomes: application
to the min system in Brucella abortus. Appl. Environ. Microbiol. 73, 1375–1379.
doi: 10.1128/AEM.01873-06
Herrera, C. M., Henderson, J. C., Crofts, A. A., and Trent, M. S. (2017). Novel
coordination of lipopolysaccharide modifications in Vibrio cholerae promotes
CAMP resistance. Mol. Microbiol. 106, 582–596. doi: 10.1111/mmi.13835
Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S.,
et al. (1992). Generation of large numbers of dendritic cells from mouse
bone marrow cultures supplemented with granulocyte/macrophage colony-
stimulating factor. J. Exp. Med. 176, 1693–1702. doi: 10.1084/jem.176.
6.1693
Iriarte, M., González, D., Delrue, R. M., Monreal, D., Conde-Álvarez, R., López-
Goñi, I., et al. (2004). “Brucella LPS: structure, biosynthesis and genetics,” in
Frontiers in Microbiology | www.frontiersin.org 12 January 2018 | Volume 8 | Article 2657
fmicb-08-02657 January 9, 2018 Time: 16:56 # 13
Conde-Álvarez et al. Genes Remodeling Brucella Cell Envelope
Brucella: Molecular and Cellular Biology, eds I. López-Goñi and I. Moriyón
(Gurgaon: Horizon Bioscience), 159–192.
Jiménez de Bagüés, M. P., Ouahrani-Bettache, S., Quintana, J. F., Mitjana, O.,
Hanna, N., Bessoles, S., et al. (2010). The new species Brucella microti replicates
in macrophages and causes death in murine models of infection. J. Infect. Dis.
202, 3–10. doi: 10.1086/653084
Jones, B. A., Grace, D., Kock, R., Alonso, S., Rushton, J., Said, M. Y., et al. (2013).
Zoonosis emergence linked to agricultural intensification and environmental
change. Proc. Natl. Acad. Sci. U.S.A. 110, 8399–8404. doi: 10.1073/pnas.
1208059110
Karbarz, M. J., Kalb, S. R., Cotter, R. J., and Raetz, C. R. H. (2003). Expression
cloning and biochemical characterization of a Rhizobium leguminosarum
lipid A 1-phosphatase. J. Biol. Chem. 278, 39269–39279. doi: 10.1074/jbc.
M305830200
Karbarz, M. J., Six, D. A., and Raetz, C. R. H. (2009). Purification and
characterization of the lipid A 1-phosphatase LpxE of Rhizobium
leguminosarum. J. Biol. Chem. 284, 414–425. doi: 10.1074/jbc.M8083
90200
Kastowsky, M., Gutberlet, T., and Bradaczek, H. (1992). Molecular modelling
of the three-dimensional structure and conformational flexibility of bacterial
lipopolysaccharide. J. Bacteriol. 174, 4798–4806. doi: 10.1128/jb.174.14.4798-
4806.1992
Kovach, M. E., Phillips, R. W., Elzer, P. H., Roop, R. M., and Peterson, K. M.
(1994). pBBR1MCS: a broad-host-range cloning vector. Biotechniques 16,
800–802.
Kubler-Kielb, J., and Vinogradov, E. (2013). The study of the core part and
non-repeating elements of the O-antigen of Brucella lipopolysaccharide.
Carbohydr. Res. 366, 33–37. doi: 10.1016/j.carres.2012.11.004
Lai, S., Zhou, H., Xiong, W., Gilbert, M., Huang, Z., Yu, J., et al. (2017). Changing
epidemiology of human brucellosis, China, 1955-2014. Emerg. Infect. Dis. 23,
184–194. doi: 10.3201/eid2302.151710
Lapaque, N., Moriyon, I., Moreno, E., and Gorvel, J.-P. (2005). Brucella
lipopolysaccharide acts as a virulence factor. Curr. Opin. Microbiol. 8, 60–66.
doi: 10.1016/j.mib.2004.12.003
Lapaque, N., Takeuchi, O., Corrales, F., Akira, S., Moriyon, I., Howard, J. C., et al.
(2006). Differential inductions of TNF-alpha and IGTP, IIGP by structurally
diverse classic and non-classic lipopolysaccharides. Cell. Microbiol. 8, 401–413.
doi: 10.1111/j.1462-5822.2005.00629.x
Leong, D., Díaz, R., Milner, K., Rudbach, J., and Wilson, J. B. (1970). Some
structural and biological properties of Brucella endotoxin. Infect. Immun 1,
174–182.
Lewis, L. A., Shafer, W. M., Dutta Ray, T., Ram, S., and Rice, P. A. (2013).
Phosphoethanolamine residues on the lipid A moiety of Neisseria gonorrhoeae
lipooligosaccharide modulate binding of complement inhibitors and resistance
to complement killing. Infect. Immun. 81, 33–42. doi: 10.1128/IAI.00751-12
Llobet, E., Martínez-Moliner, V., Moranta, D., Dahlström, K. M., Regueiro, V.,
Tomás, A., et al. (2015). Deciphering tissue-induced Klebsiella pneumoniae lipid
A structure. Proc. Natl. Acad. Sci. U.S.A. 112, E6369–E6378. doi: 10.1073/pnas.
1508820112
Mackinnon, F. G., Cox, A. D., Plested, J. S., Tang, C. M., Makepeace, K., Coull,
P. A., et al. (2002). Identification of a gene (lpt-3) required for the addition
of phosphoethanolamine to the lipopolysaccharide inner core of Neisseria
meningitidis and its role in mediating susceptibility to bactericidal killing and
opsonophagocytosis. Mol. Microbiol. 43, 931–943. doi: 10.1046/j.1365-2958.
2002.02754.x
Martínez de Tejada, G., Pizarro-Cerdá, J., Moreno, E., and Moriyón, I. (1995). The
outer membranes of Brucella spp. are resistant to bactericidal cationic peptides.
Infect. Immun. 63, 3054–3061.
Martirosyan, A., Moreno, E., and Gorvel, J.-P. (2011). An evolutionary strategy
for a stealthy intracellular Brucella pathogen. Immunol. Rev. 240, 211–234.
doi: 10.1111/j.1600-065X.2010.00982.x
Moreira, C. G., Herrera, C. M., Needham, B. D., Parker, C. T., Libby, S. J., Fang,
F. C., et al. (2013). Virulence and stress-related periplasmic protein (VisP)
in bacterial/host associations. Proc. Natl. Acad. Sci. U.S.A. 110, 1470–1475.
doi: 10.1073/pnas.1215416110
Moreno, E., Berman, D. T., and Boettcher, L. A. (1981). Biological activities of
Brucella abortus lipopolysaccharides. Infect. Immun. 31, 362–370.
Moreno, E., and Moriyón, I. (2007). “The genus Brucella,” in The Prokaryotes:
Proteobacteria, Vol. 5, eds S. Falkow, E. Rosenberg, K. H. Schleifer, E.
Stackebrandt, and M. Dworkin (Berlin: Springer-Verlag), 315–455.
Moreno, E., Stackebrandt, E., Dorsch, M., Wolters, J., Busch, M., and
Mayer, H. (1990). Brucella abortus 16S rRNA and lipid A reveal a
phylogenetic relationship with members of the alpha-2 subdivision of the class
Proteobacteria. J. Bacteriol. 172, 3569–3576. doi: 10.1128/jb.172.7.3569-3576.
1990
Moriyón, I. (2003). “Against gram-negative bacteria: the lipopolysaccharide case,”
in Intracellular Pathogens in Membrane Interactions and Vacuole Biogenesis, ed.
J. P. Gorvel (Dordrecht: Kluwer Academic Publishers), 204–230.
Naessan, C., Egge-Jacobsen, W., Heiniger, R., Wolfgang, M., Aas, F., Røhr, A., et al.
(2008). Genetic and functional analyses of PptA, a phospho-form transferase
targeting type IV pili in Neisseria gonorrhoeae. J. Bacteriol. 190, 387–400.
doi: 10.1128/JB.00765-07
Needham, B. D., and Trent, M. S. (2013). Fortifying the barrier: the impact of
lipid A remodelling on bacterial pathogenesis. Nat. Rev. Microbiol. 11, 467–481.
doi: 10.1038/nrmicro3047
Palacios-Chaves, L., Conde-Álvarez, R., Gil-Ramírez, Y., Zuñiga-Ripa, A.,
Barquero-Calvo, E., Chacón-Díaz, C., et al. (2011). Brucella abortus ornithine
lipids are dispensable outer membrane components devoid of a marked
pathogen-associated molecular pattern. PLOS ONE 6:e16030. doi: 10.1371/
journal.pone.0016030
Papadopoulos, A., Gagnaire, A., Degos, C., de Chastellier, C., and Gorvel, J.-
P. (2016). Brucella discriminates between mouse dendritic cell subsets upon
in vitro infection. Virulence 7, 33–44. doi: 10.1080/21505594.2015.1108516
Qureshi, N., Takayama, K., Seydel, U., Wang, R., Cotter, R. J., Agrawal,
P. K., et al. (1994). Structural analysis of the lipid A derived from
the lipopolysaccharide of Brucella abortus. J. Endotoxin Res. 1, 137–148.
doi: 10.1177/096805199400100303
Raetz, C. R. H., Guan, Z., Ingram, B. O., Six, D. A., Song, F., Wang, X., et al.
(2009). Discovery of new biosynthetic pathways: the lipid A story. J. Lipid Res.
50(Suppl.), S103–S108. doi: 10.1194/jlr.R800060-JLR200
Renzi, F., Zähringer, U., Chandler, C. E., Ernst, R. K., Cornelis, G. R., and Ittig,
S. J. (2015). Modification of the 1-phosphate group during biosynthesis of
Capnocytophaga canimorsus lipid A. Infect. Immun. 84, 550–561. doi: 10.1128/
IAI.01006-15
Salcedo, S. P., Marchesini, M. I., Degos, C., Terwagne, M., Von Bargen, K.,
Lepidi, H., et al. (2013). BtpB, a novel Brucella TIR-containing effector
protein with immune modulatory functions. Front. Cell. Infect. Microbiol. 3:28.
doi: 10.3389/fcimb.2013.00028
Salcedo, S. P., Marchesini, M. I., Lelouard, H., Fugier, E., Jolly, G., Balor, S.,
et al. (2008). Brucella control of dendritic cell maturation is dependent on the
TIR-containing protein Btp1. PLOS Pathog. 4:e21. doi: 10.1371/journal.ppat.
0040021
Sciorra, V. A., and Morris, A. J. (2002). Roles for lipid phosphate phosphatases
in regulation of cellular signaling. Biochim. Biophys. Acta 1582, 45–51.
doi: 10.1016/S1388-1981(02)00136-1
Scupham, A. J., and Triplett, E. W. (1997). Isolation and characterization of the
UDP-glucose 4‘-epimerase-encoding gene, galE, from Brucella abortus 2308.
Gene 202, 53–59. doi: 10.1016/S0378-1119(97)00453-8
Simon, L. D., Randolph, B., Irwin, N., and Binkowski, G. (1983). Stabilization of
proteins by a bacteriophage T4 gene cloned in Escherichia coli. Proc. Natl. Acad.
Sci. U.S.A. 80, 2059–2062. doi: 10.1073/pnas.80.7.2059
Sohlenkamp, C., Galindo-Lagunas, K. A., Guan, Z., Vinuesa, P., Robinson, S.,
Thomas-Oates, J., et al. (2007). The lipid Lysyl-phosphatidylglycerol is present
in membranes of Rhizobium tropici CIAT899 and confers increased resistance
to polymyxin B under acidic growth conditions. Mol. Plant Microbe Interact.
20, 1421–1430. doi: 10.1094/MPMI-20-11-1421
Stukey, J., and Carman, G. M. (2008). Identification of a novel phosphatase
sequence motif. Protein Sci. 6, 469–472. doi: 10.1002/pro.55600
60226
Takahashi, H., Carlson, R. W., Muszynski, A., Choudhury, B., Kim, K. S.,
Stephens, D. S., et al. (2008). Modification of lipooligosaccharide with
phosphoethanolamine by LptA in Neisseria meningitidis enhances
meningococcal adhesion to human endothelial and epithelial cells. Infect.
Immun. 76, 5777–5789. doi: 10.1128/IAI.00676-08
Frontiers in Microbiology | www.frontiersin.org 13 January 2018 | Volume 8 | Article 2657
fmicb-08-02657 January 9, 2018 Time: 16:56 # 14
Conde-Álvarez et al. Genes Remodeling Brucella Cell Envelope
Tran, A. X., Whittimore, J. D., Wyrick, P. B., Mcgrath, S. C., Cotter, R. J., and Trent,
M. S. (2006). The lipid A 1-phosphatase of Helicobacter pylori is required for
resistance to the antimicrobial peptide polymyxin. J. Bacteriol. 188, 4531–4541.
doi: 10.1128/JB.00146-06
Trombley, M. P., Post, D. M. B., Rinker, S. D., Reinders, L. M., Fortney,
K. R., Zwickl, B. W., et al. (2015). Phosphoethanolamine transferase LptA
in Haemophilus ducreyi modifies lipid A and contributes to human defensin
resistance in vitro. PLOS ONE 10:e0124373. doi: 10.1371/journal.pone.0124373
Velasco, J., Bengoechea, J. A., Brandenburg, K., Lindner, B., Seydel, U.,
González, D., et al. (2000). Brucella abortus and its closest phylogenetic relative,
Ochrobactrum spp., differ in outer membrane permeability and cationic peptide
resistance. Infect. Immun. 68, 3210–3218. doi: 10.1128/IAI.68.6.3210-3218.
2000
Vences-Guzmán, M. Á., Guan, Z., Ormeño-Orrillo, E., González-Silva, N., López-
Lara, I. M., Martínez-Romero, E., et al. (2011). Hydroxylated ornithine lipids
increase stress tolerance in Rhizobium tropici CIAT899. Mol. Microbiol. 79,
1496–1514. doi: 10.1111/j.1365-2958.2011.07535.x
Wang, X., McGrath, S. C., Cotter, R. J., and Raetz, C. R. H. (2006). Expression
cloning and periplasmic orientation of the Francisella novicida lipid A 4’-
phosphatase LpxF. J. Biol. Chem. 281, 9321–9330. doi: 10.1074/jbc.M600435200
Wang, X., Ribeiro, A. A., Guan, Z., Abraham, S. N., and Raetz, C. R. H. (2007).
Attenuated virulence of a Francisella mutant lacking the lipid A 4’-phosphatase.
Proc. Natl. Acad. Sci. U.S.A. 104, 4136–4141. doi: 10.1073/pnas.0611606104
Weissenmayer, B., Gao, J. L., Lopez-Lara, I. M., and Geiger, O. (2002).
Identification of a gene required for the biosynthesis of ornithine-derived lipids.
Mol. Microbiol. 45, 721–733. doi: 10.1046/j.1365-2958.2002.03043.x
Whatmore, A. M. (2009). Current understanding of the genetic diversity of
Brucella, an expanding genus of zoonotic pathogens. Infect. Genet. Evol. 9,
1168–1184. doi: 10.1016/j.meegid.2009.07.001
Wright, J. C., Hood, D. W., Randle, G. A., Makepeace, K., Cox, A. D., Li, J., et al.
(2004). lpt6, a gene required for addition of phosphoethanolamine to inner-
core lipopolysaccharide of Neisseria meningitidis and Haemophilus influenzae.
J. Bacteriol. 186, 6970–6982. doi: 10.1128/JB.186.20.6970-6982.2004
Zheludkov, M. M., and Tsirelson, L. E. (2010). Reservoirs of Brucella infection in
nature. Biol. Bull. 37, 709–715. doi: 10.1134/S106235901007006X
Zinsstag, J., Schelling, E., Solera, J., Blasco, J. M., and Moriyón, I. (2011).
“Brucellosis,” in Handbook of Zoonoses, eds S. R. Palmer, L. Soulsby, P. R.
Torgeson, and D. G. Brown (Oxford: Oxford University Press), 54–62.
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2018 Conde-Álvarez, Palacios-Chaves, Gil-Ramírez, Salvador-Bescós,
Bárcena-Varela, Aragón-Aranda, Martínez-Gómez, Zúñiga-Ripa, de Miguel,
Bartholomew, Hanniffy, Grilló, Vences-Guzmán, Bengoechea, Arce-Gorvel, Gorvel,
Moriyón and Iriarte. This is an open-access article distributed under the terms
of the Creative Commons Attribution License (CC BY). The use, distribution or
reproduction in other forums is permitted, provided the original author(s) or licensor
are credited and that the original publication in this journal is cited, in accordance
with accepted academic practice. No use, distribution or reproduction is permitted
which does not comply with these terms.
Frontiers in Microbiology | www.frontiersin.org 14 January 2018 | Volume 8 | Article 2657
